Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
The researchers argue that traditional vaccine development methods, which rely heavily on laboratory experimentation and long ...
Senior Manufacturing Science Associate Diane Morgan performs an analysis of plasmid DNA at Vernal Biosciences in Colchester on Tuesday, Aug. 12. Photo by Glenn Russell/VTDigger U.S. Health and Human ...
Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...
When news of the efficacy of the Covid-19 vaccine was first shared, the medical community was astounded not only by the vaccine’s ability to protect people from infection but also by the speed at ...
The Food and Drug Administration’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes. The first sign of trouble was the ...
In September 2025, the Russian Federal Medical and Biological Agency announced that a Russian cancer vaccine had passed preclinical trials with promising results. Following this announcement, posts ...
Until May, the Duke Consortia for HIV/AIDS Vaccine Development (CHAVD) had conducted its groundbreaking research with federal funding. Then the National Institutes of Health terminated the program, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback